This study was conducted to investigate the effects of Reiki and guided imagery on pain and fatigue in oncology patients. This quasi-experimental study with a pretest and posttest design was conducted with 180 oncology patients at the oncology clinic of Dicle University Hospital in Turkey, between July 2017 and February 2018. The patients were divided into three groups: Reiki, guided imagery and control, with 60 patients in each group. The Reiki and guided imagery group patients underwent their respective interventions for three consecutive days separately (25-30 min; mean: 15.53 min). The interventions of Reiki and guided imagery reduced pain and fatigue in the oncology patients. It is recommended that oncology nurses use Reiki and guided imagery in patient care.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.explore.2020.07.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cosmology of belonging: The role of community in the therapeutic use of psychedelics.
Palliat Support Care
January 2025
Assistant Attending Behavioral Scientist, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Background: The recent wave of clinical trials of psychedelic substances among patients with life-limiting illness has largely focused on individual healing. This most often translates to a single patient receiving an intervention with researchers guiding them. As social isolation and lack of connection are major drivers of current mental health crises and group work is expected to be an important aspect of psychedelic assisted psychotherapy, it is essential that we understand the role of community in psychedelic healing.
View Article and Find Full Text PDFIn August 2024, The U.S. Food and Drug Administration rejected Lykos Therapeutics, Inc.
View Article and Find Full Text PDFThe Midas Touch by Iridium: A Second Near-Infrared Aggregation-Induced Emission-Active Metallo-Agent for Exceptional Phototheranostics of Breast Cancer.
J Am Chem Soc
January 2025
Center for AIE Research, Guangdong Provincial Key Laboratory of New Energy Materials Service Safety, College of Materials Science and Engineering, Shenzhen University, Shenzhen 518060, P. R. China.
Developing small organic molecular phototheranostic agents with second near-infrared (NIR-II) aggregation-induced emission (AIE) is paramount for the phototriggered diagnostic imaging and synchronous in situ therapy of cancer via an excellent balance of the excited states energy dissipations. In this study, a multifunctional iridium(III) complex is exploited by the coordination of an AIE-active N^N ancillary ligand with a trivalent iridium ion. The resultant complex DPTPzIr significantly outperforms its parent ligand in terms of absorption/emission wavelengths, reactive oxygen species (ROS) production, and photothermal conversion, which simultaneously endow DPTPzIr nanoparticles with matched absorption peak to commercial 808 nm laser, the longest NIR-II emission peak (above 1100 nm) among those previously reported AIE iridium(III) complexes, potentiated type-I ROS generation, and as high as 60.
View Article and Find Full Text PDFThe effect of non-pharmacological methods on pain in patients undergoing open heart surgery: A systematic review and meta-analysis.
Turk Gogus Kalp Damar Cerrahisi Derg
July 2024
Department of Nursing, Tekirdağ Namık Kemal University Faculty of Medicine, Tekirdağ, Türkiye.
Background: In this meta-analysis, we aimed to determine the effect of non-pharmacological methods on pain in patients undergoing open heart surgery.
Methods: Scientific articles published between January 2002 and April 2022 were scanned in ScienceDirect, Scopus, PubMed, Web of Science, Google Scholar, Mendeley, Wiley Online Library databases. The keywords "open heart surgery," "cardiovascular surgery," "non-pharmacological," "complementary medicine," and "pain" were used in Turkish and English language.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!